These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 1843038)

  • 1. Molecular biology of coagulation.
    Pavirani A; Bischoff R
    Schweiz Med Wochenschr Suppl; 1991; 43():55-7. PubMed ID: 1843038
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular biology of the hemophilias.
    Thompson AR
    Prog Hemost Thromb; 1991; 10():175-214. PubMed ID: 1901173
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular basis of hemophilia.
    Lozier JN; High KA
    Hematol Pathol; 1990; 4(1):1-26. PubMed ID: 2111315
    [No Abstract]   [Full Text] [Related]  

  • 4. Status of gene transfer for hemophilia A and B.
    Thompson AR
    Thromb Haemost; 1991 Jul; 66(1):119-22. PubMed ID: 1926041
    [No Abstract]   [Full Text] [Related]  

  • 5. A golden age for Haemophilia treatment?
    Makris M; Hermans C
    Haemophilia; 2018 Mar; 24(2):175-176. PubMed ID: 29601683
    [No Abstract]   [Full Text] [Related]  

  • 6. The hemophilias--from royal genes to gene therapy.
    Mannucci PM; Tuddenham EG
    N Engl J Med; 2001 Jun; 344(23):1773-9. PubMed ID: 11396445
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract]   [Full Text] [Related]  

  • 8. Looking to the future of gene therapy for hemophilia A and B.
    Kaczmarek R; Herzog RW
    Expert Rev Hematol; 2023; 16(11):807-809. PubMed ID: 37798911
    [No Abstract]   [Full Text] [Related]  

  • 9. Key issues in inhibitor management in patients with haemophilia.
    Gomez K; Klamroth R; Mahlangu J; Mancuso ME; Mingot ME; Ozelo MC
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s319-29. PubMed ID: 24333092
    [No Abstract]   [Full Text] [Related]  

  • 10. [The current therapeutic bases for hemophilia].
    Négrier C
    Transfus Clin Biol; 2000 Jun; 7(3):257-8. PubMed ID: 10919215
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advances in the field of hemophilia therapy].
    Loeliger EA; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy for hemophilia: the clot thickens.
    High KA
    Hum Gene Ther; 2014 Nov; 25(11):915-22. PubMed ID: 25397928
    [No Abstract]   [Full Text] [Related]  

  • 13. Hereditary disorders of blood coagulation.
    Zieve PD; Levin J
    Major Probl Intern Med; 1976; 10():51-64. PubMed ID: 785116
    [No Abstract]   [Full Text] [Related]  

  • 14. The evolution of recombinant factor replacement for hemophilia.
    Sankar AD; Weyand AC; Pipe SW
    Transfus Apher Sci; 2019 Oct; 58(5):596-600. PubMed ID: 31421983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biology of blood coagulation disorders].
    Saito H
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1682-6. PubMed ID: 1685509
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific therapy in hemophilia.
    Hutaff LW
    N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
    [No Abstract]   [Full Text] [Related]  

  • 17. [Structure and function of factor VIII and factor IX gene and molecular DNA diagnosis in hemophilia A and B].
    Herrmann FH; Wehnert M; Wulff K
    Z Arztl Fortbild (Jena); 1988; 82(22):1116-22. PubMed ID: 2907834
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant blood clotting proteins for hemophilia therapy.
    Limentani SA; Roth DA; Furie BC; Furie B
    Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hemophilia].
    Stavem P; Hjort PF
    Tidsskr Nor Laegeforen; 1970 Jul; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract]   [Full Text] [Related]  

  • 20. Pioneering therapeutic proteins in hemophilia care through innovative technologies.
    Pabinger-Fasching I; Négrier C
    Thromb Res; 2016 May; 141 Suppl 3():S1. PubMed ID: 27288062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.